Used as a key chiral intermediate in the synthesis of pharmaceutical agents, particularly in the development of kinase inhibitors. Its structural features enable selective binding to enzyme targets, making it valuable in the production of drugs for oncology and inflammatory diseases. The compound's stereochemistry enhances biological activity and specificity, which is critical for optimizing drug efficacy and reducing off-target effects. It is commonly employed in late-stage functionalization processes during API manufacturing.